SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.98 Cr | ₹-1.30 Cr | ₹-1.43 Cr | ₹0.28 Cr | ₹-0.02 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-0.98 Cr |
| Mar2025 | ₹-1.30 Cr |
| Mar2024 | ₹-1.43 Cr |
| Mar2023 | ₹0.28 Cr |
| Mar2022 | ₹-0.02 Cr |
How is Deferred Tax Assets / Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.98 Cr | Negative | |
| Mar2025 | ₹-1.30 Cr | Negative | |
| Mar2024 | ₹-1.43 Cr | Negative | |
| Mar2023 | ₹0.28 Cr | Positive | |
| Mar2022 | ₹-0.02 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹129.9 Cr | 21.2% | 5.4% | -15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | 21.2% |
5.4% |
-15.4% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses